STOCK TITAN
  1. Home
  2. Sec-filings
  3. QDEL
  4. [Form 4] QuidelOrtho Corp Insider Trading Activity

QuidelOrtho (QDEL) director awarded 6,829 shares via RSU vesting

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

QuidelOrtho Corp director Evelyn S. Dilsaver reported an equity award and related vesting of restricted stock units. On May 29, 2026, she acquired 6,829 shares of common stock at no cost through the release of previously reported restricted stock units. Each unit converted into one share of common stock when the units vested on May 29, 2026. Following these transactions, she directly holds 17,453 shares of QuidelOrtho common stock, and the reported restricted stock unit grant has been fully exercised.

Positive

  • None.

Negative

  • None.
Insider Dilsaver Evelyn S
Role null
Type Security Shares Price Value
Exercise Restricted Stock Units (Equity Grant) 6,829 $0.00 --
Grant/Award Common Stock 6,829 $0.00 --
Holdings After Transaction: Restricted Stock Units (Equity Grant) — 0 shares (Direct, null); Common Stock — 17,453 shares (Direct, null)
Footnotes (1)
  1. Reflects release of restricted stock units that were previously reported on a Form 4. Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. The restricted stock units vested on May 29, 2026.
Shares acquired via award 6,829 shares Common stock received through RSU release on May 29, 2026
Post-transaction holdings 17,453 shares Common stock directly held after transactions
RSUs exercised 6,829 units Restricted stock units converted to common stock
Exercise/award price $0.00 per share Equity award and RSU conversion price
Restricted Stock Units financial
"Reflects release of restricted stock units that were previously reported on a Form 4."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
derivative security financial
"Exercise or conversion of derivative security"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
Form 4 regulatory
"previously reported on a Form 4."
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
vested financial
"The restricted stock units vested on May 29, 2026."
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Dilsaver Evelyn S
(Last)(First)(Middle)
9975 SUMMERS RIDGE ROAD
(Street)
SAN DIEGO CALIFORNIA 92121
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
QuidelOrtho Corp [ QDEL ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/29/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock05/29/2026A6,829(1)A$017,453D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Units (Equity Grant)(2)05/29/2026M6,829 (3) (3)Common Stock6,829$00D
Explanation of Responses:
1. Reflects release of restricted stock units that were previously reported on a Form 4.
2. Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.
3. The restricted stock units vested on May 29, 2026.
Remarks:
/s/ Phillip S. Askim, attorney-in-fact for Evelyn S. Dilsaver06/02/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did QuidelOrtho (QDEL) director Evelyn S. Dilsaver report?

Evelyn S. Dilsaver reported acquiring shares through an equity award. She received 6,829 shares of QuidelOrtho common stock at no cost via vesting and conversion of previously granted restricted stock units on May 29, 2026.

How many QuidelOrtho (QDEL) shares did Evelyn S. Dilsaver receive in this Form 4?

She received 6,829 shares of QuidelOrtho common stock. These came from the release and conversion of 6,829 restricted stock units, with each unit representing the right to receive one share upon vesting on May 29, 2026.

Was Evelyn S. Dilsaver’s QuidelOrtho (QDEL) transaction a market purchase or sale?

It was neither a market purchase nor a sale. The Form 4 shows a grant or award acquisition and an exercise of restricted stock units at a price of $0.00 per share, reflecting compensation-related vesting rather than open-market trading.

How many QuidelOrtho (QDEL) shares does Evelyn S. Dilsaver hold after these transactions?

After the reported transactions, she directly holds 17,453 shares of QuidelOrtho common stock. The restricted stock unit position associated with this award is shown as fully exercised, with zero derivative units remaining following conversion to common shares.

What happened to the restricted stock units reported in Evelyn S. Dilsaver’s QuidelOrtho (QDEL) Form 4?

Previously reported restricted stock units vested and converted into common shares. On May 29, 2026, 6,829 restricted stock units vested, each unit delivering one share of QuidelOrtho common stock, leaving no remaining units from this specific equity grant.